Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
AssigneeVerrica Pharmaceuticals Inc.
InventorsMatthew Davidson, Steven R. Schow
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for synthesizing cantharidin and cantharidin derivatives.
Claims33
A method for generating a cantharidin formulation comprising cantharidin or a cantharidin derivative, the method comprising reacting a precursor of said cantharidin or cantharidin derivative to form said cantharidin formulation having said cantharidin or cantharidin derivative at an exo-to-endo ratio of at least 6:1.
2-8. (canceled)
10-12. (canceled)
A method for generating a cantharidin formulation comprising cantharidin or a cantharidin derivative, the method comprising reacting a precursor of said cantharidin or cantharidin derivative to form said cantharidin formulation having said cantharidin or cantharidin derivative, wherein said reacting is conducted (i) in the absence of diethyl ether, (ii) in the absence of a lithium or magnesium salt, and (iii) at a pressure less than about 980 atmospheres (atm).
15-21. (canceled)
23-24. (canceled)
27-29. (canceled)
A cantharidin formulation comprising (i) cantharidin or a cantharidin derivative, (ii) less than 0.1% diethyl ether and (iii) less than 0.1% lithium salt, wherein said cantharidin or cantharidin derivative is at an exo-to-endo ratio of at least 6:1.
31-36. (canceled)
A cantharidin formulation comprising (i) cantharidin or a cantharidin derivative and (ii) a Lewis catalyst comprising one or more Lewis metals selected from the group consisting of Li (I), Mg (II), B (III), Al (III), Ti (IV), Zr (IV), Zn (II), Cu(I), Cu (II), Sn (II), Sn (IV), Si (IV), La (III), Sc (III), Yb (III), Eu (III), Ga (III), Sb (V), Nb (V), Fe (III), and Co (III), wherein said one or more Lewis metals are at concentration of at least about 1 part per billion (ppb).
38-40. (canceled)
A process for preparing cantharidin or a derivative thereof, comprising:
- a) providing a first compound of formula (1):
- b) forming a second compound having formula (2) from said first compound:
- c) performing a cycloaddition reaction on said second compound to yield a third compound having formula (3):
- and
- d) generating said cantharidin or derivative thereof from said third compound.
42-71. (canceled)
A process, comprising:
- a) providing a first compound of formula (1):
- and
- b) forming a second compound having formula (2):
- from said first compound by subjecting said first compound to a hydrolysis reaction that is performed using NaOH.
A process, comprising:
- a) providing a first compound of formula (1):
- and
- b) forming a second compound having formula (2):
- from said first compound by subjecting said first compound to a dehydration reaction that includes exposing said compound of formula (1) to an acyl halide.
(canceled)
A process, comprising:
- a) providing a first compound of formula (1):
- wherein X is selected from the group consisting of S, O, CH2, CHR1, CR1R2, NH, NR1, and NR1R2, wherein said R1 and R2 are each independently selected from an alkyl, aryl, heteroaryl, alkoxy, amine, alcohol, and halogen or together are a carbonyl, alkenyl, imine, or oxime, wherein said R1 and R2 are each optionally independently substituted;
- and
- b) forming a second compound having formula (2):
- wherein X is selected from the group consisting of S, O, CH2, CHR1, CR1R2, NH, NR1, and NR1R2, wherein said R1 and R2 are each independently selected from an alkyl, aryl, heteroaryl, alkoxy, amine, alcohol, and halogen or together are a carbonyl, alkenyl, imine, or oxime, wherein said R1 and R2 are each optionally independently substituted, from said first compound by subjecting said first compound to a cycloaddition reaction that includes exposing said first compound to at least one Lewis acid selected from the group consisting of Table 1, magnesium perchlorate, aluminum chloride, lithium trifluoromethanesulfonate, tin(II) trifluoromethanesulfonate, bis(cyclopentadienyl)zirconium(IV) bis(trifluoromethanesulfonate)tetrahydrofuran complex, bis(cyclopentadienyl)titanium(IV) bis(trifluoromethanesulfonate), boron trifluoride diethyl etherate, gallium(III) chloride, copper(II) tetrafluoroborate hydrate, aluminum bromide, niobium(V) chloride, ytterbium(III) trifluoromethanesulfonate, scandium(III) trifluoromethanesulfonate, magnesium trifluoromethanesulfonate, trimethylsilyl trifluoromethanesulfonate, and copper(II) trifluoromethanesulfonate.
76-80. (canceled)
A process for preparing cantharidin, comprising:
- a) providing a first compound that is selected from any one of:
- and
- b) generating said cantharidin from said first compound by subjecting said first compound to a reduction reaction that includes hydrogenation and desulfurization reactions performed using separate reducing agents, wherein said desulfurization reaction is performed using a reducing agent selected from Table 2 that is not Raney Nickel.
82-83. (canceled)
A process, comprising:
- a) providing a compound of formula (1) or (2):
- and
- b) forming a compound having a structure selected from the group consisting of
- from said compound of formula (1) or (2) by subjecting said compound of formula (1) or (2) to an oxidation reaction.
(canceled)
A process, comprising:
- a) providing a compound having a structure selected from the group consisting of
- and
- b) forming a compound having a structure selected from the group consisting of
- from said compound provided in (a) by subjecting said compound provided in (a) to an oxidation reaction.
(canceled)
A composition having a structure selected from the group consisting of:
A pharmaceutically acceptable mixture having a composition that is selected from any one of:
Dependencies are inferred from the claim text.